- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/02 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
Patent holdings for IPC class C07D 241/02
Total number of patents in this class: 113
10-year publication summary
|
3
|
6
|
2
|
6
|
4
|
6
|
5
|
4
|
7
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Medibeacon, Inc. | 137 |
8 |
| Merck Sharp & Dohme LLC | 3753 |
7 |
| Betta Pharmaceuticals Co., Ltd. | 180 |
3 |
| MannKind Corporation | 523 |
3 |
| Nippon Shinyaku Co., Ltd. | 324 |
3 |
| Novartis AG | 10721 |
2 |
| Bristol-myers Squibb Company | 4849 |
2 |
| Hoffmann-La Roche Inc. | 3478 |
2 |
| Merck Sharp & Dohme Corp. | 2190 |
2 |
| Janssen Pharmaceutica N.V. | 3367 |
2 |
| Pfizer Inc. | 3386 |
2 |
| Abbvie Inc. | 1806 |
2 |
| Toyama Chemical Co., Ltd. | 101 |
2 |
| Crinetics Pharmaceuticals, Inc. | 120 |
2 |
| Shanghai Forefront Pharma Co., Ltd. | 4 |
2 |
| Glaxo Group Limited | 4122 |
1 |
| F. Hoffmann-La Roche AG | 7948 |
1 |
| BASF SE | 21017 |
1 |
| Centre National de La Recherche Scientifique | 10564 |
1 |
| Amgen Inc. | 4108 |
1 |
| Other owners | 64 |